EX-23.1 11 amag-20151231ex23156999d.htm EX-23.1 amag_EX_23_1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation by reference in the Registration Statements on Forms S‑3 (File Nos. 333‑192132, 333‑202009 and 333-202252) and Forms S‑8 (File Nos. 333‑82292, 333‑131656, 333‑148682, 333‑159938, 333‑168786, 333‑182821, 333‑190435, 333‑197873 and 333-203924) of AMAG Pharmaceuticals, Inc. of our report dated February 24, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.

 

 

 

 

/s/ PricewaterhouseCoopers LLP

 

Boston, Massachusetts

February 24, 2016